Literature DB >> 14752167

Cross-linking cellular prion protein triggers neuronal apoptosis in vivo.

Laura Solforosi1, Jose R Criado, Dorian B McGavern, Sebastian Wirz, Manuel Sánchez-Alavez, Shuei Sugama, Lorraine A DeGiorgio, Bruce T Volpe, Erika Wiseman, Gil Abalos, Eliezer Masliah, Donald Gilden, Michael B Oldstone, Bruno Conti, R Anthony Williamson.   

Abstract

Neuronal death is a prominent, but poorly understood, pathological hallmark of prion disease. Notably, in the absence of the cellular prion protein (PrPC), the disease-associated isoform, PrPSc, appears not to be intrinsically neurotoxic, suggesting that PrPC itself may participate directly in the prion neurodegenerative cascade. Here, cross-linking PrPC in vivo with specific monoclonal antibodies was found to trigger rapid and extensive apoptosis in hippocampal and cerebellar neurons. These findings suggest that PrPC functions in the control of neuronal survival and provides a model to explore whether cross-linking of PrPC by oligomeric PrPSc can promote neuronal loss during prion infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14752167     DOI: 10.1126/science.1094273

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  110 in total

1.  Spontaneous generation of anchorless prions in transgenic mice.

Authors:  Jan Stöhr; Joel C Watts; Giuseppe Legname; Abby Oehler; Azucena Lemus; Hoang-Oanh B Nguyen; Joshua Sussman; Holger Wille; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions.

Authors:  Koji Fujita; Yoshitaka Yamaguchi; Tsuyoshi Mori; Naomi Muramatsu; Takahito Miyamoto; Masashi Yano; Hironori Miyata; Akira Ootsuyama; Makoto Sawada; Haruo Matsuda; Ryuji Kaji; Suehiro Sakaguchi
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 3.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

4.  In vitro neutralization of prions with PrP(Sc)-specific antibodies.

Authors:  Ryan Taschuk; Jacques Van der Merwe; Kristen Marciniuk; Andrew Potter; Neil Cashman; Philip Griebel; Scott Napper
Journal:  Prion       Date:  2015       Impact factor: 3.931

5.  Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies.

Authors:  Gaetano Donofrio; Frank L Heppner; Magdalini Polymenidou; Christine Musahl; Adriano Aguzzi
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Lethal recessive myelin toxicity of prion protein lacking its central domain.

Authors:  Frank Baumann; Markus Tolnay; Christine Brabeck; Jens Pahnke; Ulrich Kloz; Hartmut H Niemann; Mathias Heikenwalder; Thomas Rülicke; Alexander Bürkle; Adriano Aguzzi
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 7.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 8.  Copper and the prion protein: methods, structures, function, and disease.

Authors:  Glenn L Millhauser
Journal:  Annu Rev Phys Chem       Date:  2007       Impact factor: 12.703

9.  Scrapie-induced defects in learning and memory of transgenic mice expressing anchorless prion protein are associated with alterations in the gamma aminobutyric acid-ergic pathway.

Authors:  Matthew J Trifilo; Manuel Sanchez-Alavez; Laura Solforosi; Joie Bernard-Trifilo; Stefan Kunz; Dorian McGavern; Michael B A Oldstone
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.